Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 925-292-5 | CAS number: -
Carcinogenicity
Administrative data
Description of key information
A two part carcinogenicity study was conducted on both rats and mice to determine the oncogenic effects of inhalation exposure of commercial hexane solvent.
No NOAEC level was calculated for local irritation effects. The LOAEC level for both sexes was 900 ppm. No oncogenic effects were seen in the exposure groups. The NOAEC for systemic effects was 9016 ppm in rats of both sexes.
Key value for chemical safety assessment
Justification for classification or non-classification
Commercial hexane solvent containing between 5 and 80% n-hexane is not classified for carcinogenicity.
Additional information
In a two part study the oncogenic effects of inhalation exposure of commercial hexane solvent (~52% n-hexane) was conducted on male and female mice and male and female rats (Daughtrey, 1999; Klimisch score =1). In Part I of the study groups of 50 male and 50 female rats were exposed to 0, 900, 3000, or 9016 ppm of test substance for 6 hrs/day, 5 days/week, for 2 yrs. Mortalities of exposure groups were consistant with control groups. Body weight gain was significantly reduced in exposure groups. Histopathology revealed dose-related effects in the nasoturbinal tissue in all exposure groups. Therefore, there was no NOAEC level for local irritation effects. The LOAEC level for both sexes was 900 ppm. No oncogenic effects were seen in the exposure groups. The NOAEC for systemic effects was 9016 ppm in rats of both sexes.
In Part II of the study groups of 50 male and 50 female mice were exposed to 0, 900, 3000, or 9018 ppm (0, 3168, 10560, 31680 mg/m3) of test substance for 6 hrs/day, 5 days/week, for 2 yrs. Mortalities of exposure groups were consistant with control groups. Histopathology revealed increased liver masses and nodules in female mice at the 9018 ppm exposure group. As referenced in NTP, 2004, liver tumors in B6C3F1 mice are known to be sensitive to body weight changes, especially in female B6C3F1 mice. Therefore, the increased incidence of liver masses and nodules in female mice should be interpreted with care. The NOAEC level for oncogenic effects in female mice is 3000 ppm (10560 mg/m3). The LOAEC for female mice was 9018 ppm (31680 mg/m3). No oncogenic effects were seen in male mice. The NOAEC level for oncogenic effects in male mice is 9018 ppm (31680 mg/m3).
This study directly informs the DNEL.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
